Abstract
Neuroinflammation is a typical feature of many neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. Microglia, the resident immune cells of the brain, readily become activated in response to an infection or an injury. Uncontrolled and overactivated microglia can release pro-inflammatory and cytotoxic factors and are the major culprits in neuroinflammation. Hence, research on novel neuroinflammatory inhibitors is of paramount importance for the treatment of neurodegenerative diseases. Bacterial lipopolysaccharide, widely used in the studies of brain inflammation, initiates several major cellular activities that critically contribute to the pathogenesis of neuroinflammation. This review will highlight the progress on terpenoids, an important and structurally diverse group of natural compounds, as neuroinflammatory inhibitors in lipopolysaccharidestimulated BV-2 microglial cells over the last 20 years.
Keywords: Neuroinflammation, Alzheimer's disease, Parkinson's disease, microglia, terpenoids, lipopolysaccharide.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia
Volume: 21 Issue: 4
Author(s): Yuanzhen Xu, Hongbo Wei and Jinming Gao*
Affiliation:
- Shaanxi Key Laboratory of Natural Products and Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi,China
Keywords: Neuroinflammation, Alzheimer's disease, Parkinson's disease, microglia, terpenoids, lipopolysaccharide.
Abstract: Neuroinflammation is a typical feature of many neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. Microglia, the resident immune cells of the brain, readily become activated in response to an infection or an injury. Uncontrolled and overactivated microglia can release pro-inflammatory and cytotoxic factors and are the major culprits in neuroinflammation. Hence, research on novel neuroinflammatory inhibitors is of paramount importance for the treatment of neurodegenerative diseases. Bacterial lipopolysaccharide, widely used in the studies of brain inflammation, initiates several major cellular activities that critically contribute to the pathogenesis of neuroinflammation. This review will highlight the progress on terpenoids, an important and structurally diverse group of natural compounds, as neuroinflammatory inhibitors in lipopolysaccharidestimulated BV-2 microglial cells over the last 20 years.
Export Options
About this article
Cite this article as:
Xu Yuanzhen , Wei Hongbo and Gao Jinming *, Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia, Mini-Reviews in Medicinal Chemistry 2021; 21 (4) . https://dx.doi.org/10.2174/1389557519666190611124539
DOI https://dx.doi.org/10.2174/1389557519666190611124539 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Clinical Pharmacology of Short Acting Analgo-Sedatives in Neonates
Current Clinical Pharmacology Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
Current Medicinal Chemistry Is Renalase a Novel Player in Catecholaminergic Signaling? The Mystery of the Catalytic Activity of an Intriguing New Flavoenzyme
Current Pharmaceutical Design Allosteric Modulators of GABAB Receptors: Mechanism of Action and Therapeutic Perspective
Current Neuropharmacology Editorial: Systems Genetics of Alzheimer’s Disease: From GWAS to Disease Pathways
Current Alzheimer Research Diffusion Tensor Imaging in Alzheimers Disease
Current Medical Imaging Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research
Current Pharmaceutical Design Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Postranslational Modification of Ion Channels in Colonic Inflammation
Current Neuropharmacology Function of Cytosolic Chaperones in Tom70-Mediated Mitochondrial Import
Protein & Peptide Letters Review of Pediatric Uveitis
Current Pediatric Reviews Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Beyond Rodent Models of Pain: Non-Human Primate Models for Evaluating Novel Analgesic Therapeutics and Elaborating Pain Mechanisms
CNS & Neurological Disorders - Drug Targets Acculturation and Substance Use among Hispanic-Latino and Asian Adolescents
Current Psychiatry Reviews Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Neuroprotection and Behavior Regulation by Adrenomedullin and PAMP as Shown by Conditional Knockout Models
Current Hypertension Reviews Cyclosporine A Loaded Solid Lipid Nanoparticles: Optimization of Formulation, Process Variable and Characterization
Current Drug Delivery Oxidative Stress and Heavy Metal Levels of Pholiota limonella Mushroom Collected from Different Regions
Current Chemical Biology